+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Cancer Marker"

Biomarkers and Companion Diagnostics in Oncology - Product Thumbnail Image

Biomarkers and Companion Diagnostics in Oncology

  • Report
  • December 2018
  • 113 Pages
  • Global
From
Database of Biomarkers Curated from US Oncology Trials, 2021 - Product Thumbnail Image

Database of Biomarkers Curated from US Oncology Trials, 2021

  • Database
  • December 2021
  • United States
From
From
From
From
From
From
From
From
From
From
From
From
From
Loading Indicator

Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, such as cancer. Cancer markers are a type of biomarker that can be used to detect the presence of cancer in a patient. They can be used to diagnose, monitor, and predict the progression of cancer. Cancer markers can be proteins, hormones, enzymes, or other molecules that are produced by cancer cells or are associated with the presence of cancer. Cancer markers are used in a variety of ways, including to detect the presence of cancer, to monitor the progression of the disease, and to predict the response to treatment. They can also be used to identify patients who are at risk for developing cancer. The cancer marker market is a rapidly growing segment of the biomarker market. It is driven by the increasing prevalence of cancer, the development of new technologies for detecting and monitoring cancer, and the increasing demand for personalized medicine. Companies in the cancer marker market include Abbott Laboratories, Agilent Technologies, Becton Dickinson, Bio-Rad Laboratories, Cepheid, and Roche Diagnostics. Show Less Read more